» Articles » PMID: 39225352

A Framework for the Design of Risk-Adjustment Models in Health Care Provider Payment Systems

Overview
Specialty Health Services
Date 2024 Sep 3
PMID 39225352
Authors
Affiliations
Soon will be listed here.
Abstract

Prospective payments for health care providers require adequate risk adjustment (RA) to address systematic variation in patients' health care needs. However, the design of RA for provider payment involves many choices and difficult trade-offs between incentives for risk selection, incentives for cost control, and feasibility. Despite a growing literature, a comprehensive framework of these choices and trade-offs is lacking. This article aims to develop such a framework. Using literature review and expert consultation, we identify key design choices for RA in the context of provider payment and subsequently categorize these choices along two dimensions: (a) the choice of risk adjusters and (b) the choice of payment weights. For each design choice, we provide an overview of options, trade-offs, and key references. By making design choices and associated trade-offs explicit, our framework facilitates customizing RA design to provider payment systems, given the objectives and other characteristics of the context of interest.

References
1.
Horn S, Horn R, Sharkey P . The Severity of Illness Index as a severity adjustment to diagnosis-related groups. Health Care Financ Rev. 1983; Suppl:33-45. PMC: 4195109. View

2.
Lamers L . Pharmacy costs groups: a risk-adjuster for capitation payments based on the use of prescribed drugs. Med Care. 1999; 37(8):824-30. DOI: 10.1097/00005650-199908000-00012. View

3.
Schokkaert E, Van de Voorde C . Risk selection and the specification of the conventional risk adjustment formula. J Health Econ. 2004; 23(6):1237-59. DOI: 10.1016/S0167-6296(03)00040-7. View

4.
Chang H, Lee W, Weiner J . Comparison of alternative risk adjustment measures for predictive modeling: high risk patient case finding using Taiwan's National Health Insurance claims. BMC Health Serv Res. 2010; 10:343. PMC: 3022875. DOI: 10.1186/1472-6963-10-343. View

5.
Garcia-Goni M, Ibern P, Inoriza J . Hybrid risk adjustment for pharmaceutical benefits. Eur J Health Econ. 2008; 10(3):299-308. DOI: 10.1007/s10198-008-0133-2. View